Incyte Corporation Stock News

(CercleFinance.com) - Le 3ème trimestre démarrage pour les chapeaux de roues pour le Nasdaq (+1,1%) qui inscrit un nouveau record absolu de clôture à …

In a tug of war between bulls and bears, the Dow Jones and S&P; 500 gained at least 1% each last week while the Nasdaq Composite Index advanced over 3%.

Shares of Gilead Sciences Inc. undefined were down 1.2% in trading on Monday after the drugmaker said it plans to start Phase 1 clinical trials for an...

Shares of Gilead Sciences Inc. were down 1.2% in trading on Monday after the drugmaker said it plans to start Phase 1 clinical trials for an inhaled version of remdesivir, its treatment for severely

Incyte (INCY) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

In a tug of war between bulls and bears, the Dow Jones and S&P 500 gained at least 1% each last week while the Nasdaq Composite Index advanced over 3%.

Incyte (INCY) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

(CercleFinance.com) - Les jeux étaient fait dès l'ouverture, et c'est souvent le cas à Wall Street lors de la journée des '4 sorcières' : les acheteurs …

Major equity indexes in the US trade in the negative territory. Incyte Corp (INCY) trades at its highest level since early June. Cruise liner stocks

It's a face-off between an incredibly cheap stock and a pharmaceutical giant.

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80%

Incyte Investor Conference Update.

Stocks Analysis by Zacks Investment Research covering: Eli Lilly and Company, Bed Bath & Beyond Inc, TJX Companies Inc, Take-Two Interactive Software Inc. Read Zacks Investment Research's latest artic

The company said it had initiated the Phase III study of Olumiant, one of multiple JAK inhibitors that are being tested to find if they can mitigate the cytokine storm associated with Covid-19's worst